None listed
Conditions
Interventions
None listed
Sponsors
Chonnam National University Hospital
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: - Male or female patients = 18 years - Patients diagnosed with type 2 DM, on metformin monotherapy, who will be prescribed a new OAD or an OAD fixed-dose combination as dual combination therapy according to local label/prescribing requirements. - 7=HbA1c=11 - Patients give informed consent to have their data collected and agree to follow prescribing requirements
Exclusion criteria
Exclusion criteria: - Patients who require three or more OAD or insulin at time of study entry. - Patients who are switched from one OAD or class to another at time of study entry. - History of hypersensitivity to any of the study drug. - Patients who are attending other study and use of any drug. - Patients who are taking SUs other than glimepiride at study entry -Patients for whom the investigator would consider another SU than glimepiride during the course of the trial - Patients treated with glinides at study entry -patients for which a treatment with glinides would be considered during the course of the study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Dual drug withdrawal(failure) means, patients who need three OAD or more or insulin or HbA1c >7.5% twice ( 2 consecutive failure) | — |
Countries
Korea, Republic of
Contacts
Public ContactJin wook Jung
Chonnam National University Hospital
Outcome results
None listed